Study Debunks Notion That Antidepressant Might Ease COVID Symptoms
MONDAY, Sept. 18, 2023 (HealthDay News) — A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms. The study, led by Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University, foundContinue Reading